Chart

Aligos Therapeutics, Inc.

ALGS

Jan 1 1970 00:00:00

9.24

▲0.25▲2.78%

Open9.12

High9.47

Low9.12

Close8.99

Volume1.27k

EPS

-10.24

P/E

-0.9023

Market Cap

393.71M

Outstanding Shares

42.61M

Soon

Sentiment

Soon

Options

Recent Filings

ID: 0001610717-24-000503

ID: 0001610717-24-000495

ID: 0001783647-24-000001

ID: 0001610717-24-000466

ID: 0001610717-24-000465

ID: 0001610717-24-000464

ID: 0001193125-24-214188

ID: 0001193125-24-202813

ID: 0001610717-24-000423

ID: 0001610717-24-000422

You might find these companies interesting

Lexeo Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Quince Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Biological Products, (No Diagnostic Substances) (2836)

Chromocell Therapeutics Corp

Biological Products, (No Diagnostic Substances) (2836)

Vigil Neuroscience, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Inhibrx Biosciences, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Finch Therapeutics Group, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Crispr Therapeutics Ag

Biological Products, (No Diagnostic Substances) (2836)

Cannabis Global, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Cero Therapeutics Holdings, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Senti Biosciences, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Adaptimmune Therapeutics Plc

Biological Products, (No Diagnostic Substances) (2836)

Cerevel Therapeutics Holdings, Inc.

Pharmaceutical Preparations (2834)

Stoke Therapeutics, Inc.

Pharmaceutical Preparations (2834)